Literature DB >> 1596599

Treatment recommendations for anticonvulsant drug therapy in the older patient.

P D Swanson1.   

Abstract

Seizures in older individuals are frequently due to cerebrovascular disease, though other causes, such as primary or metastic brain tumour, must be considered. Recurrence after a first seizure may be as high as 83% by 3 years, suggesting that withholding an anticonvulsant after a first seizure may not be wise. Some older patients may be more sensitive to anticonvulsant side effects, so treatment with 1 drug is encouraged, with monitoring of blood concentrations of the anticonvulsant during initiation of therapy. Interaction of anticonvulsants with other drugs is less of a problem than may be expected, but should be kept in mind. The treatment of status epilepticus should be aggressive.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596599     DOI: 10.2165/00002512-199202020-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  23 in total

Review 1.  Epilepsy in old age.

Authors:  R Tallis
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

Review 2.  Convulsive disorders: the use of anticonvulsant drugs.

Authors:  T P Bleck
Journal:  Clin Neuropharmacol       Date:  1990-06       Impact factor: 1.592

Review 3.  Pharmacokinetic consequences of aging.

Authors:  D P Richey; A D Bender
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

4.  The effects of age on carbamazepine pharmacokinetics and adverse effects.

Authors:  N Hockings; A Pall; J Moody; A V Davidson; D L Davidson
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

Review 5.  The clinical pharmacology of antiepileptic drugs.

Authors:  J Bruni; P S Albright
Journal:  Clin Neuropharmacol       Date:  1984       Impact factor: 1.592

6.  Pharmacokinetics of valproic acid in the elderly.

Authors:  E Perucca; R Grimaldi; G Gatti; S Pirracchio; F Crema; G M Frigo
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

7.  Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1981-08       Impact factor: 5.864

8.  A survey of epileptic disorders in southwest France: seizures in elderly patients.

Authors:  J Loiseau; P Loiseau; B Duché; M Guyot; J F Dartigues; B Aublet
Journal:  Ann Neurol       Date:  1990-03       Impact factor: 10.422

9.  Pentobarbital treatment of refractory status epilepticus.

Authors:  M C Rashkin; C Youngs; P Penovich
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

10.  National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population.

Authors:  J W Sander; Y M Hart; A L Johnson; S D Shorvon
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

View more
  1 in total

Review 1.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.